Cargando…

Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice

Renal cell carcinoma (RCC) is the seventh most common cancer in men and the ninth most common cancer in women worldwide. There is plenty of evidence about the role of the immune system in surveillance against tumors. Thanks to a better understanding of immunosurveillance mechanisms, immunotherapy ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lasorsa, Francesco, di Meo, Nicola Antonio, Rutigliano, Monica, Milella, Martina, Ferro, Matteo, Pandolfo, Savio Domenico, Crocetto, Felice, Tataru, Octavian Sabin, Autorino, Riccardo, Battaglia, Michele, Ditonno, Pasquale, Lucarelli, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136190/ https://www.ncbi.nlm.nih.gov/pubmed/37189689 http://dx.doi.org/10.3390/biomedicines11041071

Ejemplares similares

Cellular and Molecular Players in the Tumor Microenvironment of Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Cancer Stem Cells in Renal Cell Carcinoma: Origins and Biomarkers
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Metabolomic Approaches for Detection and Identification of Biomarkers and Altered Pathways in Bladder Cancer
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
por: di Meo, Nicola Antonio, et al.
Publicado: (2022)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Novel Insights into Autophagy and Prostate Cancer: A Comprehensive Review
por: Loizzo, Davide, et al.
Publicado: (2022)

Radiogenomics in Renal Cancer Management—Current Evidence and Future Prospects
por: Ferro, Matteo, et al.
Publicado: (2023)

Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice
por: Loizzo, Davide, et al.
Publicado: (2022)

MUC1 Tissue Expression and Its Soluble Form CA15-3 Identify a Clear Cell Renal Cell Carcinoma with Distinct Metabolic Profile and Poor Clinical Outcome
por: Lucarelli, Giuseppe, et al.
Publicado: (2022)

MUC1 Expression Affects the Immunoflogosis in Renal Cell Carcinoma Microenvironment through Complement System Activation and Immune Infiltrate Modulation
por: Lucarelli, Giuseppe, et al.
Publicado: (2023)

Emerging Urinary Markers of Renal Injury in Obstructive Nephropathy
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

The Impact of Meat Intake on Bladder Cancer Incidence: Is It Really a Relevant Risk?
por: Aveta, Achille, et al.
Publicado: (2022)

The Efficacy of Flogofilm(®) in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
por: Barone, Biagio, et al.
Publicado: (2023)

Robotic partial nephrectomy for large renal Leiomyoma: first case report
por: Franco, Antonio, et al.
Publicado: (2023)

Radiomics in prostate cancer: an up-to-date review
por: Ferro, Matteo, et al.
Publicado: (2022)

A Rare Case of Solitary Fibrous Tumour of the Pelvis in an 18-Year-Old Young Man: CT and MRI Features with Pathologic Correlations
por: Ascione, Raffaele, et al.
Publicado: (2020)

Use of Intravesical Injections of Platelet-Rich Plasma for the Treatment of Bladder Pain Syndrome: A Comprehensive Literature Review
por: Trama, Francesco, et al.
Publicado: (2021)

Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review
por: Ferro, Matteo, et al.
Publicado: (2023)

8-Hydroxy-2-Deoxyguanosine and 8-Iso-Prostaglandin F2α: Putative Biomarkers to assess Oxidative Stress Damage Following Robot-Assisted Radical Prostatectomy (RARP)
por: Di Minno, Alessandro, et al.
Publicado: (2022)

Molecular Imaging Diagnosis of Renal Cancer Using (99m)Tc-Sestamibi SPECT/CT and Girentuximab PET-CT-Current Evidence and Future Development of Novel Techniques
por: Tataru, Octavian Sabin, et al.
Publicado: (2023)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

Artificial Intelligence in the Advanced Diagnosis of Bladder Cancer-Comprehensive Literature Review and Future Advancement
por: Ferro, Matteo, et al.
Publicado: (2023)

Prostate Cancer Radiogenomics—From Imaging to Molecular Characterization
por: Ferro, Matteo, et al.
Publicado: (2021)

Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study
por: Tarantino, Giovanni, et al.
Publicado: (2021)

Radiotherapy to the Primary Tumor: The First Step of a Tailored Therapy in Metastatic Prostate Cancer
por: Ferro, Matteo, et al.
Publicado: (2022)

Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
por: Tarantino, Giovanni, et al.
Publicado: (2021)

Fascin-1 and its role as a serological marker in prostate cancer: a prospective case–control study
por: Tătaru, Octavian Sabin, et al.
Publicado: (2021)

Renal Cell Carcinoma: A Study through NMR-Based Metabolomics Combined with Transcriptomics
por: Ragone, Rosa, et al.
Publicado: (2016)

Diagnostic and Prognostic Role of Preoperative Circulating CA 15-3, CA 125, and Beta-2 Microglobulin in Renal Cell Carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2014)

A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors
por: Pandolfo, Savio Domenico, et al.
Publicado: (2023)

Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2015)

Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma
por: Lucarelli, Giuseppe, et al.
Publicado: (2018)

Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Crocetto, Felice, et al.
Publicado: (2021)

Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review
por: Aveta, Achille, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors as a Neoadjuvant/Adjuvant Treatment of Muscle-Invasive Bladder Cancer: A Systematic Review
por: Barone, Biagio, et al.
Publicado: (2022)

Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma
por: Vavallo, Antonio, et al.
Publicado: (2014)

Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma
por: Gigante, Margherita, et al.
Publicado: (2015)

Penile prosthesis implant for primary erectile dysfunction in patient with Klippel-Trenaunay syndrome complicated by consumptive coagulopathy: A case report
por: Bettocchi, Carlo, et al.
Publicado: (2019)

The Three-Gene Signature in Urinary Extracellular Vesicles from Patients with Clear Cell Renal Cell Carcinoma
por: De Palma, Giuseppe, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ctj450bc91d9qm6ros2nf2cdlm